Zobrazeno 1 - 10 of 841 pro vyhledávání: '"Loach D"'
1
Akademický článek
Using stable isotopes to investigate movement of fish in rice paddy fields.
Autor: Jaeyong Lee1 (AUTHOR), Jae-Ok Kim2 (AUTHOR), Owen, Jeffrey S.3 (AUTHOR) owenjef2002@gmail.co, Bomchul Kim4 (AUTHOR)
Publikováno v: International Aquatic Research. Sep2015, Vol. 7 Issue 3, p211-220. 10p. 1 Chart, 4 Graphs, 1 Map.
Zobrazit plný text záznamu
2
Akademický článek
Dual T-cell depletion with ATG and PTCy for peripheral blood reduced intensity conditioning allo-HSCT results in very low rates of GVHD.
Autor: Salas MQ; Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology. Princes Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Prem S; Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology. Princes Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Atenafu EG; Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Datt Law A; Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology. Princes Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Lam W; Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology. Princes Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Al-Shaibani Z; Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology. Princes Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Loach D; Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology. Princes Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Kim DDH; Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology. Princes Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Michelis FV; Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology. Princes Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Lipton JH; Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology. Princes Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Kumar R; Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology. Princes Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Mattsson J; Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology. Princes Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Viswabandya A; Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology. Princes Margaret Cancer Centre, University Health Network, Toronto, ON, Canada. auro.viswabandya@uhn.ca.
Publikováno v: Bone marrow transplantation [Bone Marrow Transplant] 2020 Sep; Vol. 55 (9), pp. 1773-1783. Date of Electronic Publication: 2020 Feb 05.
Zobrazit plný text záznamu
3
Akademický článek
Predictors of Outcomes of Therapy-Related Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation.
Autor: Nampoothiri RV; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Princess Margaret Cancer Center, University of Toronto, Toronto, ON, Canada., Law AD; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Princess Margaret Cancer Center, University of Toronto, Toronto, ON, Canada., Lam W; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Princess Margaret Cancer Center, University of Toronto, Toronto, ON, Canada., Chen C; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Princess Margaret Cancer Center, University of Toronto, Toronto, ON, Canada., Al-Shaibani Z; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Princess Margaret Cancer Center, University of Toronto, Toronto, ON, Canada., Loach D; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Princess Margaret Cancer Center, University of Toronto, Toronto, ON, Canada., Michelis FV; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Princess Margaret Cancer Center, University of Toronto, Toronto, ON, Canada., Kim DDH; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Princess Margaret Cancer Center, University of Toronto, Toronto, ON, Canada., Mattsson J; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Princess Margaret Cancer Center, University of Toronto, Toronto, ON, Canada., Kumar R; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Princess Margaret Cancer Center, University of Toronto, Toronto, ON, Canada., Lipton JH; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Princess Margaret Cancer Center, University of Toronto, Toronto, ON, Canada., Viswabandya A; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Princess Margaret Cancer Center, University of Toronto, Toronto, ON, Canada.
Publikováno v: Hematology/oncology and stem cell therapy [Hematol Oncol Stem Cell Ther] 2022 Mar 01; Vol. 15 (1), pp. 27-35. Date of Electronic Publication: 2022 Mar 01.
Zobrazit plný text záznamu
4
Akademický článek
Reduced-intensity conditioning allogeneic transplant with dual T-cell depletion in myelofibrosis.
Autor: Salas MQ; Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Lam W; Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Law AD; Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Kim DDH; Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Michelis FV; Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Loach D; Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Al-Shaibani Z; Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Lipton JH; Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Kumar R; Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Mattsson J; Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Viswabandya A; Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
Publikováno v: European journal of haematology [Eur J Haematol] 2019 Dec; Vol. 103 (6), pp. 597-606. Date of Electronic Publication: 2019 Sep 30.
Zobrazit plný text záznamu
5
Akademický článek
Reduced intensity allogeneic stem cell transplant with anti-thymocyte globulin and post-transplant cyclophosphamide in acute myeloid leukemia.
Autor: Salas MQ; Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Prem S; Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Atenafu EG; Department of Biostatistics, Princes Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Law AD; Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Lam W; Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Al-Shaibani Z; Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Loach D; Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Kim DDH; Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Michelis FV; Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Lipton JH; Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Kumar R; Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Mattsson J; Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Viswabandya A; Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
Publikováno v: European journal of haematology [Eur J Haematol] 2019 Nov; Vol. 103 (5), pp. 510-518. Date of Electronic Publication: 2019 Sep 09.
Zobrazit plný text záznamu
6
Akademický článek
Event-related potentials of stimuli inhibition and access in cross-modal distractor-induced blindness.
Autor: Hanke, Sophie1 (AUTHOR) sophie.hanke@fu-berlin.de, Niedeggen, Michael1 (AUTHOR)
Publikováno v: PLoS ONE. 10/23/2024, Vol. 19 Issue 10, p1-28. 28p.
Zobrazit plný text záznamu
7
Akademický článek
Safety of two-hour intermittent intravenous infusions of tacrolimus in the allogeneic hematopoietic stem cell transplantation unit.
Autor: Bacopoulos AJ; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Canada.; Department of Pharmacy, University Health Network, Toronto, Canada., Ho L; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Canada.; Department of Pharmacy, University Health Network, Toronto, Canada.; Messner Allogeneic Transplant Program, University Health Network, Toronto, Canada., Yang A; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Canada.; Department of Pharmacy, University Health Network, Toronto, Canada., Ng P; Department of Pharmacy, University Health Network, Toronto, Canada., Dara C; Department of Pharmacy, University Health Network, Toronto, Canada., Loach D; Messner Allogeneic Transplant Program, University Health Network, Toronto, Canada.; Faculty of Medicine, University of Toronto, Toronto, Canada., Deotare U; Messner Allogeneic Transplant Program, University Health Network, Toronto, Canada.; Faculty of Medicine, University of Toronto, Toronto, Canada., Michelis FV; Messner Allogeneic Transplant Program, University Health Network, Toronto, Canada.; Faculty of Medicine, University of Toronto, Toronto, Canada., Viswabandya A; Messner Allogeneic Transplant Program, University Health Network, Toronto, Canada.; Faculty of Medicine, University of Toronto, Toronto, Canada., Kim DD; Messner Allogeneic Transplant Program, University Health Network, Toronto, Canada.; Faculty of Medicine, University of Toronto, Toronto, Canada., Lipton JH; Messner Allogeneic Transplant Program, University Health Network, Toronto, Canada.; Faculty of Medicine, University of Toronto, Toronto, Canada., Messner HA; Messner Allogeneic Transplant Program, University Health Network, Toronto, Canada.; Faculty of Medicine, University of Toronto, Toronto, Canada., Thyagu S; Messner Allogeneic Transplant Program, University Health Network, Toronto, Canada.; Faculty of Medicine, University of Toronto, Toronto, Canada.
Publikováno v: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2021 Jan; Vol. 27 (1), pp. 33-39. Date of Electronic Publication: 2020 Mar 17.
Zobrazit plný text záznamu
8
Akademický článek
Outcomes of therapy-related acute lymphoblastic leukemia in adults after allogeneic stem cell transplantation.
Autor: Vasudevan Nampoothiri R; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Princess Margaret Cancer Center, University of Toronto, Toronto, ON, Canada., Law AD; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Princess Margaret Cancer Center, University of Toronto, Toronto, ON, Canada., Lam W; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Princess Margaret Cancer Center, University of Toronto, Toronto, ON, Canada., Chen C; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Princess Margaret Cancer Center, University of Toronto, Toronto, ON, Canada., Al-Shaibani Z; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Princess Margaret Cancer Center, University of Toronto, Toronto, ON, Canada., Loach D; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Princess Margaret Cancer Center, University of Toronto, Toronto, ON, Canada., Michelis FV; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Princess Margaret Cancer Center, University of Toronto, Toronto, ON, Canada., Kim DDH; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Princess Margaret Cancer Center, University of Toronto, Toronto, ON, Canada., Mattsson J; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Princess Margaret Cancer Center, University of Toronto, Toronto, ON, Canada., Kumar R; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Princess Margaret Cancer Center, University of Toronto, Toronto, ON, Canada., Lipton JH; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Princess Margaret Cancer Center, University of Toronto, Toronto, ON, Canada., Viswabandya A; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Princess Margaret Cancer Center, University of Toronto, Toronto, ON, Canada.
Publikováno v: European journal of haematology [Eur J Haematol] 2020 Jul; Vol. 105 (1), pp. 24-29. Date of Electronic Publication: 2020 Mar 18.
Zobrazit plný text záznamu
9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
10
Akademický článek
The Emergence of the Slc11 Clade MCb gut : A Parsimonious Hypothesis for the Dawn of Lactobacillales in the Gut of Early Vertebrates.
Autor: Cellier, Mathieu F. M.1 mathieu.cellier@inrs.ca
Publikováno v: Bacteria (2674-1334). Sep2024, Vol. 3 Issue 3, p223-255. 33p.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje